Looking to publish in BioDrugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowBioDrugs is a hybrid journal covering the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease, serving R&D professionals and clinicians interested in biologic therapies.
Looking to publish in BioDrugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
BioDrugs accepts the following article types. Click on an article type to view submission instructions.
Review Article
Systematic Review
Original Research
Narrative Reviews
Meta-Analysis
Summary Of Research Articles (Sras)
Letter To The Editor
Recent Publications
Why Product Drift Is Not an Issue for Biosimilars/Biologics: Start the Same, Stay the Same
Joseph P. Park, Hyunhee Oh, Gillian R. Woollett
Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis
Carlos Roberto Montes-de-Oca-Saucedo, Laura Ghanem, Najwaa Kirmani, Bruno Briceño-Villardaga, Andrea Michelle Talancon-Solana, Adela Jatzari Salinas-Ocampo, Grecia Sereno-Acevedo, Adolfo Soto-Domínguez, Raquel Rivera-Díaz
Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
Zhihua Ran, Yan Chen, Yinglei Miao, Yufang Wang, Xiang Gao, Jie Zhong, Xueli Ding, Chengdang Wang, Xiaolan Zhang, Yijuan Ding, Naizhong Hu, Dan Tang, Jiao Yu, Chenxi Qian, Jun Shen
Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities
Rebecca J. Wilson, Charmaine A. Ramlogan-Steel, William J. Deasy, Sarah J. Greenstein, Christopher J. Layton, Jason C. Steel
An Overview and Trend Analysis of Biosimilar Approvals in China
Mei Yang, Ning Zhang, Haixue Wang
Frequently asked questions
How long does it take to publish?
Accepted articles are published online after receipt of the corrected proofs.
Reformat to BioDrugs using Livewrite PremiumIs a cover letter required?
A cover letter is used when unpublished material is included in the manuscript and when suggesting reviewers the corresponding author should include reviewer identity details in the submission letter.
Reformat to BioDrugs using Livewrite PremiumWhat are the publication costs?
Open access APC: £3790.00 GBP / $5490.00 USD / €4490.00 EUR. Subscription publishing has no APC charges.
Reformat to BioDrugs using Livewrite Premium